Takeda Pharmaceutical Company Limited (TYO:4502)
6,950.00
+81.00 (1.18%)
Nov 19, 2026, 3:30 PM JST
Takeda Pharmaceutical Company Employees
Takeda Pharmaceutical Company had 47,029 employees as of March 31, 2026. The number of employees decreased by 426 or 0.90% compared to the previous year. That makes Takeda Pharmaceutical Company the 764th largest employer in the world and 70th in Japan.
Employees
47,029
Change (1Y)
-426
Growth (1Y)
-0.90%
Revenue / Employee
99.79M JPY
Profits / Employee
867.44K JPY
Market Cap
11.10T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 47,029 | -426 | -0.90% |
| Mar 31, 2025 | 47,455 | -1,826 | -3.71% |
| Mar 31, 2024 | 49,281 | 186 | 0.38% |
| Mar 31, 2023 | 49,095 | 1,748 | 3.69% |
| Mar 31, 2022 | 47,347 | 248 | 0.53% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Eisai | 10,543 |
| Shionogi & | 6,223 |
| Sumitomo Pharma | 4,980 |
| Tsumura & Co. | 4,923 |
| Towa Pharmaceutical | 4,923 |
| Sawai Group Holdings | 3,630 |
| Nippon Shinyaku | 2,309 |
| Kissei Pharmaceutical | 1,786 |
Takeda Pharmaceutical Company News
- 2 days ago - Takeda Pharmaceutical Company Transcript: Jefferies Global Healthcare Conference - Transcripts
- 3 days ago - Takeda price target raised to $26.70 from $21.90 at BofA - TheFly
- 7 days ago - Alkermes position intact after Takeda drug pricing, says Needham - TheFly
- 7 days ago - Takeda Pharmaceutical's ORZEYFUL Is Now Available In US For Narcolepsy Type 1 Treatment - Nasdaq
- 7 days ago - Takeda announces Orzeyful CIV is now available in U.S. - TheFly
- 7 days ago - Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdle - Reuters
- 7 days ago - Takeda Launches ORZEYFUL™ (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States - Business Wire
- 20 days ago - Friday's ETF Movers: PPH, PSI - Nasdaq